Literature DB >> 11849564

Prognostic implications of microvessel morphometry in diffuse astrocytic neoplasms.

P Korkolopoulou1, E Patsouris, N Kavantzas, A E Konstantinidou, P Christodoulou, E Thomas-Tsagli, A Pananikolaou, C Eftychiadis, P M Pavlopoulos, D Angelidakis, D Rologis, P Davaris.   

Abstract

Astrocytic brain tumours, particularly malignant astrocytomas, are recognized to be highly vascular neoplasms with potent angiogenic activity. Recent research has shown that quantification of microvessel density (MVD), as a measure of the degree of angiogenesis, constitutes a strong prognostic indicator in patients with astrocytomas. However, the significance of other morphometric aspects of microvessel network has not been tested so far. In this report, histological sections from 70 astrocytomas (grades II to IV), immunostained for CD34, were evaluated by image analysis for the quantification of MVD, total vascular area (TVA), and microvascular branching, as well as several morphometric parameters related to vessel size or shape. Minor axis length increased with grade (P = 0.045) but MVD and TVA presented a peak in grade III (P = 0.033 and P < 0.001, respectively). Size and shape related parameters affected survival in univariate analysis of grade IV and grades II/III, respectively. In multivariate analysis, only branching counts, along with age and grade, were the independent predictors of survival. Although MVD, TVA and branching counts were adversely related to disease-free survival in grades II and III (univariate analysis), only TVA remained statistically significant in multivariate analysis. It is concluded that TVA and branching counts are prognostically more informative than MVD for patients with diffuse astrocytic tumours.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11849564     DOI: 10.1046/j.1365-2990.2002.00367.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  22 in total

1.  Expression of pERK and pAKT in human astrocytomas: correlation with IDH1-R132H presence, vascular endothelial growth factor, microvascular characteristics and clinical outcome.

Authors:  Angelica A Saetta; Georgia Levidou; Elias A El-Habr; Ioannis Panayotidis; Vassilis Samaras; Irene Thymara; Stratigoula Sakellariou; Efstathios Boviatsis; Efstratios Patsouris; Penelope Korkolopoulou
Journal:  Virchows Arch       Date:  2011-04-15       Impact factor: 4.064

2.  Glioma morphology and tumor-induced vascular alterations revealed in seven rodent glioma models by in vivo magnetic resonance imaging and angiography.

Authors:  Sabrina Doblas; Ting He; Debbie Saunders; Jamie Pearson; Jessica Hoyle; Nataliya Smith; Megan Lerner; Rheal A Towner
Journal:  J Magn Reson Imaging       Date:  2010-08       Impact factor: 4.813

3.  Angiogenic patterns and their quantitation in high grade astrocytic tumors.

Authors:  Suash Sharma; Mehar C Sharma; Deepak Kumar Gupta; Chitra Sarkar
Journal:  J Neurooncol       Date:  2006-06-29       Impact factor: 4.130

4.  Expression of interleukin-8 receptor CXCR2 and suppressor of cytokine signaling-3 in astrocytic tumors.

Authors:  Penelope Korkolopoulou; Georgia Levidou; Elias A El-Habr; Christos Adamopoulos; Vassilis Samaras; Athanasios Zisakis; Nikolaos Kavantzas; Efstathios Boviatsis; Paraskevi Fragkou; Athanasios G Papavassiliou; Efstratios Patsouris; Christina Piperi
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

5.  Cyclooxygenase-2 expression in astrocytomas. Relationship with microvascular parameters, angiogenic factors expression and survival.

Authors:  Marina Perdiki; Penelope Korkolopoulou; Irene Thymara; George Agrogiannis; Christina Piperi; Efstathios Boviatsis; Xenophon Kotsiakis; Dimitrios Angelidakis; Kalliopi Diamantopoulou; Euphemia Thomas-Tsagli; Efstratios Patsouris
Journal:  Mol Cell Biochem       Date:  2006-07-26       Impact factor: 3.396

6.  Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade glioma.

Authors:  L S Hu; J M Eschbacher; A C Dueck; J E Heiserman; S Liu; J P Karis; K A Smith; W R Shapiro; D S Pinnaduwage; S W Coons; P Nakaji; J Debbins; B G Feuerstein; L C Baxter
Journal:  AJNR Am J Neuroradiol       Date:  2011-11-17       Impact factor: 3.825

7.  Angiogenic switch during tumor progression of carcinoma ex-pleomorphic adenoma.

Authors:  A B Soares; P B Juliano; V C Araujo; K Metze; A Altemani
Journal:  Virchows Arch       Date:  2007-06-26       Impact factor: 4.064

8.  Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme.

Authors:  Jeannette R Flynn; Libo Wang; David L Gillespie; Gregory J Stoddard; Jason K Reid; Jason Owens; Grant B Ellsworth; Karen L Salzman; Anita Y Kinney; Randy L Jensen
Journal:  Cancer       Date:  2008-09-01       Impact factor: 6.860

9.  Dynamic MR imaging for functional vascularization depends on tissue factor signaling in glioblastoma.

Authors:  Xiao Chen; Tian Xie; Jingqin Fang; Wei Xue; Houyi Kang; Haipeng Tong; Yu Guo; Bo Zhang; Sumei Wang; Yizeng Yang; Weiguo Zhang
Journal:  Cancer Biol Ther       Date:  2018-02-06       Impact factor: 4.742

10.  Perfusion imaging of brain tumors using arterial spin-labeling: correlation with histopathologic vascular density.

Authors:  T Noguchi; T Yoshiura; A Hiwatashi; O Togao; K Yamashita; E Nagao; T Shono; M Mizoguchi; S Nagata; T Sasaki; S O Suzuki; T Iwaki; K Kobayashi; F Mihara; H Honda
Journal:  AJNR Am J Neuroradiol       Date:  2008-01-09       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.